Best Online HRT Providers for Menopause in 2026

What we actually verified

The verified comparison table

This is the part you came here for. Every number below comes from the provider’s own pricing pages as of May 26, 2026. Pricing changes — that’s why we publish a “last verified” date instead of pretending nothing moves.

What are the best online HRT providers for menopause in 2026?

Most pages tell you “Midi is the best!” or “Winona wins!” and move on. That’s lazy. The right provider depends on five things, and they flip the answer fast:

1. Do you have PPO insurance? Yes → Midi is almost always your cheapest real cost.
2. Are you paying cash? Then it’s Alloy or Evernow first.
3. Do you want FDA-approved medication? Then start with Midi, Alloy, Evernow, Gennev, or Pandia.
4. Do you specifically want compounded customization (creams mixed at a compounding pharmacy)? Then Winona.
5. Is your main issue vaginal dryness? Then Wisp (cheap) or Alloy (full menu).

We rank Midi #1 overall because insurance billing is the single biggest cost-saver for most women, and most U.S. women have some form of commercial coverage. We rank Alloy #2 because if you don’t have insurance, you should be able to see the price before you commit — and Alloy is one of the only providers that publishes per-product pricing publicly.

No provider on this list is right for everyone. We’re saying: tell us what you have, and we can tell you where to start.

How much does online HRT for menopause cost in 2026?

Here’s the trap most people fall into: they compare one number across providers (the membership price or the medication price) and ignore the others. The number that actually matters is your first-90-day total cost, because that’s what hits your card.

Three real cost numbers to think about:

1. The visit or membership fee. What the platform charges to access a clinician.
2. The medication cost. Separate at most providers — and bigger than the membership at many.
3. The labs cost (if any). Some providers include them, most don’t.

Let’s run the math for the most common menopause regimen — an FDA-approved estradiol patch plus progesterone for a woman with a uterus.

Cash-pay 90-day cost — patch + progesterone protocol

Wisp follows a different (vaginal-only) protocol and is not directly comparable on a systemic regimen.

If you have PPO insurance, Midi flips from “highest sticker price” to often the cheapest real cost, because your insurance covers the visit at your standard specialist copay and your meds run through your regular pharmacy where insurance applies too. That’s why we lead with Midi for insured readers.

If you’re cash-pay, Alloy is the cleanest comparison at roughly $294 for 90 days of meds (plus the consult fee). Evernow is the cheapest membership-only at $129 for 90 days, but medication is on top.

A real Reddit user shopping for online HRT once vented that getting clear pricing felt “like pulling teeth,” followed by “please just tell me your price?” We hear that. Half the reason this page exists is because nobody publishes clean numbers in one place.

Which online HRT providers actually take insurance?

If you have a PPO plan

Start with Midi. Midi is in-network with most PPO plans, and its own pricing page lists self-pay rates only as a backup at $250 initial and $150 follow-up. If your plan is in-network, you pay your standard specialist-visit copay or coinsurance and that’s it for the visit. Meds go to your regular pharmacy.

Important: Midi says it is not enrolled with Medicaid or Medi-Cal. Midi is not covered by Medicare or Medicare-related plans, though Midi can accept Medicare beneficiaries as self-pay patients — those beneficiaries cannot submit claims for Midi visits, medications, or associated services.

If you have an HMO or a high-deductible plan

The answer gets messier. Some HMOs don’t cover any out-of-network telehealth. Some HDHP plans have a $5,000+ deductible — meaning you’re effectively cash-pay until you hit it.

In those cases, run the math. If your HDHP makes you pay full price for any visit anyway, you may save money by going cash-pay with Alloy or Evernow and using your HSA card. The visit cost is predictable, no surprise EOBs.

If you have Medicare or Medicaid

Most online menopause-specific providers in this comparison do not bill Medicare or Medicaid for visits. The honest reality: Midi cannot treat Medicaid or Medi-Cal patients and is not covered by Medicare. Evernow says it does not currently support Medicare or Medicaid coverage. Pandia’s pharmacy accepts some Medicaid plans for medication, but not for consultation.

Your three real options:

1. Use your existing in-network doctor or OB-GYN under your Medicare or Medicaid plan, even if menopause isn’t their specialty.
2. Go cash-pay at a lower-cost telehealth option (Evernow at $49/month, Wisp at $99 if your need is local/vaginal) and use HSA funds if eligible.
3. Find a Menopause Society Certified Practitioner near you at menopause.org’s practitioner directory — many take Medicare.

FDA-approved vs. compounded HRT — the difference that actually matters

Three terms to know

• FDA-approved: The medication (the actual finished pill, patch, gel, or cream) has been tested by the FDA. Dosing is consistent batch to batch. Insurance often covers it. Examples: Estrace (oral estradiol), Climara and Vivelle-Dot (estradiol patches), Divigel (estradiol gel), Prometrium (oral micronized progesterone), Estring and Vagifem (vaginal estrogen), Bijuva (combined estradiol/progesterone capsule).
• Bioidentical: Hormones chemically identical to the ones your body makes. This includes estradiol and micronized progesterone. Important: bioidentical does NOT mean compounded. Many FDA-approved hormones are bioidentical. The marketing has confused this on purpose for years.
• Compounded: A pharmacy mixes the medication for you, often in a custom dose or form. Compounded hormones are not FDA-reviewed for safety, effectiveness, or quality.

Which provider uses which?

If “is this FDA-approved?” matters to you (and for most first-time HRT patients, it should), start with anyone in row 1, or with Winona’s FDA-approved options if you specifically want a single provider that offers both.

When compounded actually makes sense

Compounded hormones are appropriate when:

• You have an allergy to an inactive ingredient (dye, preservative) in an FDA-approved product.
• You need a dose or form that doesn’t exist commercially.
• Your clinician has a specific medical reason, not just a preference.

Compounded is notsafer or “more natural” than FDA-approved bioidentical. ACOG’s 2023 clinical consensus on this is plain: compounded bioidentical menopausal hormone therapy should not be prescribed routinely when FDA-approved formulations exist.

The 2026 FDA labeling change — what it actually means

What changed

For more than 20 years, every estrogen-containing menopause hormone therapy product carried a “black box” warning — the FDA’s strongest safety warning — about increased risk of heart disease, breast cancer, and dementia. Those warnings were based on the 2002 Women’s Health Initiative (WHI) study.

A long line of researchers said the WHI was misinterpreted. The study used older women (average age 63) starting an older synthetic progestin formulation, and applied the findings to women in their 40s and 50s starting modern bioidentical hormones. That’s not the same population, and it’s not the same medication.

The FDA’s November 10, 2025 panel and the February 12, 2026 labeling action were the federal government finally saying so. New labels reflect current evidence: for healthy women under 60 starting within 10 years of menopause, HRT carries different (often more favorable) risk-benefit math than the old black box implied.

What did NOT change

The FDA kept the boxed warning about endometrial cancer for systemic estrogen-only products. That risk is real for women with a uterus who take estrogen without progesterone protection. If you have a uterus and you’re prescribed systemic estrogen, you should also be prescribed progesterone or a progestogen to protect the uterine lining. A responsible online HRT provider will address this explicitly before prescribing systemic estrogen to a patient with a uterus. If a provider tries to prescribe estrogen alone without addressing this, walk away.

What this means for your provider choice

It doesn’t change which provider is best — but it does change the conversation. You should hear your online HRT clinician explain risk in terms of your age, your time since menopause, your formulation (oral vs. transdermal estrogen carries different clot risk), and your personal history. If your provider isn’t talking about risk in personalized terms, that’s a red flag. The new labels make those conversations easier, not optional.

What about the 2026 estradiol patch shortage?

This is the question almost no other “best providers” page is addressing. We are, because it’s the question that’s about to send you back to the search results six weeks after you start.

Why the shortage happened

Three forces hit at once: the FDA’s November 2025 labeling change removed the black box warning, demand for transdermal estradiol jumped sharply, and manufacturers couldn’t ramp up production fast enough. CVS Health confirmed that manufacturers had been unable to deliver sufficient supply in recent weeks. Amazon Pharmacy notified customers that estradiol twice-weekly patch orders could be impacted by the industry-wide shortage. Hims & Hers told Reuters in April 2026 that it had secured steady estrogen patch inventory for eligible patients.

What to do if your patch is out of stock

Your online HRT clinician can pivot you. Ask about:

• A different patch brand. Estradiol patches come in multiple brands (Vivelle-Dot, Climara, Mylan generic, and others). If one brand is out at your pharmacy, another may still be in stock.
• Estradiol gel (Divigel, Estrogel) — same hormone, daily skin application, FDA-approved.
• Oral estradiol short-term, knowing oral estrogen carries a higher risk of venous blood clots than transdermal forms. Discuss this with your clinician.

If you’re worried about getting started and then losing access, choose a provider with multiple medication forms available (Midi, Alloy, Hers) rather than one limited to a single delivery method.

Is online HRT for menopause actually safe?

You’re not being reckless by considering online HRT. You’re being cautious by asking this question. Good.

What legitimate online HRT looks like

A legitimate online menopause HRT provider will:

• Require a real prescription (not “just send me hormones”)
• Be staffed by clinicians licensed in your state
• Review your full medical history during intake
• Screen for contraindications (estrogen-sensitive cancer, blood clots, stroke, active liver disease, unexplained bleeding)
• Address progesterone if you still have a uterus and you’re getting systemic estrogen
• Explain whether your medication is FDA-approved or compounded
• Offer follow-up care, not just a one-time prescription
• Publish pricing and cancellation terms before you sign up

Each provider we rank as a primary pick is checked against this list; any unverified item is marked in the comparison table.

Red flags to walk away from

• “No doctor needed” or “no consultation required”
• Hormones sold without a prescription
• Compounded products marketed as FDA-approved
• Hidden pricing — you can’t see what you’ll pay until after you’ve created an account
• No follow-up offered
• Guaranteed symptom relief or weight loss claims
• Provider won’t tell you the clinician’s name or credentials

Who should NOT start with online HRT

Online care is not the right starting point if you have:

• A current diagnosis of breast cancer or other estrogen-sensitive cancer
• Recent history of blood clots, stroke, or heart attack
• Active liver disease
• Unexplained vaginal bleeding (needs an in-person workup, not a telehealth prescription)
• A complex medication situation requiring careful drug-interaction review
• Possible pregnancy

For these situations, find a Menopause Society Certified Practitioner near you at the Menopause Society practitioner directory and start with in-person care.

Do you need blood tests before online HRT for menopause?

The blood-test question is a real friction point. Many women have been told by their PCP that they need a lab panel before HRT, only to discover the lab panel doesn’t actually answer the question. Here’s what each provider’s policy looks like:

When labs do matter

A clinician should order labs (or refer you for in-person care) if you have:

• Unexplained vaginal bleeding
• Possible pregnancy
• Early menopause or premature ovarian insufficiency (before age 45)
• Suspected thyroid symptoms
• A complex medication history
• A history of breast cancer, blood clots, or stroke
• Uncontrolled blood pressure
• Atypical symptoms that don’t match a typical menopause pattern

What medications can online menopause HRT providers prescribe?

Estradiol (the main estrogen)

Estradiol is the most-prescribed estrogen for menopause. Online providers prescribe it in several FDA-approved forms:

• Oral estradiol (pills). Cheapest. Higher clot risk than transdermal forms.
• Estradiol patch (Climara, Vivelle-Dot, Mylan generic). Most-prescribed transdermal option. Lower clot risk than oral. Currently in tight supply at many pharmacies — see the patch shortage section above.
• Estradiol gel (Divigel, Estrogel). Daily skin application. FDA-approved and an alternative when patches are scarce.
• Estradiol vaginal cream (Estrace cream). Used for vaginal dryness and local symptoms. Lower systemic absorption.
• Estradiol vaginal ring (Estring, Femring). Inserted; releases estrogen over weeks to months.
• Estradiol vaginal tablet (Vagifem, Yuvafem).

Progesterone (uterine protection)

If you have a uterus and you’re prescribed systemic estrogen, you also need progesterone or a progestogen to protect the uterine lining. Online providers commonly prescribe:

• Micronized progesterone (Prometrium, generic). FDA-approved. Bioidentical. Often taken at bedtime — many women find it helps sleep.
• Synthetic progestins (medroxyprogesterone, norethindrone). Less commonly prescribed in online menopause care because evidence favors micronized progesterone for safety profile, but some plans still cover them.

Hers, for example, offers oral progesterone alongside estradiol pills, patches, and vaginal cream. Alloy publishes per-product pricing for progesterone starting at $23/month. Winona offers progesterone capsules from $39/month.

Vaginal estrogen and GSM

Genitourinary syndrome of menopause (GSM) — vaginal dryness, painful sex, urinary symptoms — often responds to low-dose vaginal estrogen. Vaginal estrogen has very low systemic absorption and is often appropriate even for women who can’t take systemic HRT. Wisp specifically focuses on this protocol at $20/month for the cream.

Non-hormonal options

If you can’t or don’t want to take hormones, your online provider may discuss:

• Paroxetine (Brisdelle). FDA-approved at low dose for hot flashes.
• Fezolinetant (Veozah). FDA-approved non-hormonal option for moderate to severe vasomotor symptoms.
• Gabapentin. Off-label for hot flashes and sleep disruption.

A note on testosterone

There is no FDA-approved testosterone product for women in the U.S. Some online providers prescribe testosterone off-label for menopause symptoms (low libido, energy, muscle mass), but testosterone is a Schedule III controlled substance and requires a prescription from a licensed clinician with appropriate oversight. If testosterone is part of your conversation, expect a real clinical workup, not a quick online checkout.

Best online HRT providers, in depth

Here’s each provider, ranked by overall fit. Each section opens with the verdict, then the evidence, then who should pick this provider — and who should not.

Midi Health — Best overall for insured patients

Verified facts (May 26, 2026):

• In-network with most PPO plans
• Self-pay pricing: $250 initial visit / $150 continued-care visit
• Cannot treat Medicaid or Medi-Cal patients
• Not covered by Medicare or Medicare-related plans; can accept Medicare beneficiaries as self-pay patients
• Prescribes FDA-approved hormone therapy by default
• Clinicians focus on midlife women’s health
• Available in all 50 states
• Visit model: scheduled video visits

Why we ranked it #1 overall:For most women with commercial PPO insurance, Midi will be cheaper than any flat-rate cash-pay subscription because your insurance covers the visit at your standard specialist copay and your meds go to your regular pharmacy where insurance covers them too. Midi’s clinicians focus exclusively on midlife women’s health — they’re not generalists who saw one menopause patient last month.

Who should NOT pick Midi:If you have Medicaid or Medi-Cal; if you have Medicare and need Medicare-covered care; if you’re paying cash and want the lowest sticker price; if you specifically want compounded bioidentical hormones; if you need same-day prescribing without a scheduled visit.

The damaging admission:Midi does NOT offer a flat-rate monthly subscription. Self-pay visits cost $150–$250, which is higher than Evernow’s $49/month membership or Winona’s $89/month medication-only price. If predictable subscription pricing is your priority, those are better-fit platforms. But because Midi bills like a clinical practice instead of a subscription service, your insurance can actually pay for the visit, your prescriptions go to a pharmacy that takes insurance, and the clinician you see has menopause-specific training. For most insured women, Midi’s “higher” cash-pay price is actually the lower real cost.

Alloy — Best cash-pay option with prices upfront

Verified facts (May 26, 2026):

• Estradiol pill (FDA-approved generic) from $39.99/month
• Estradiol gel from $69.99/month
• Estradiol patch from $74.99/month
• Vaginal estradiol cream from $39.99/month (billed as a 3-month supply)
• Progesterone from $23/month
• One-time consultation/care fee [verify in checkout]
• Does not accept insurance
• HSA/FSA eligibility, reimbursement receipts, and state availability [verify in intake or checkout]
• FDA-approved by default

Why we ranked it #2:Price transparency is rare in this industry. Most providers won’t tell you the medication cost until after intake. Alloy publishes it. That alone makes it the cleanest cash-pay comparison.

Who should NOT pick Alloy: If you have a strong PPO plan (Midi will almost always be cheaper); if you want compounded customization as your primary protocol; if you want insurance to cover the visit.

The strength under the surface:Alloy’s medication menu is broader than most — oral estradiol, gel, patch, vaginal cream, plus non-hormonal options for women who can’t take or don’t want hormones.

Evernow — Best lower-cost ongoing care with messaging

Verified facts (May 26, 2026):

• Membership: $49/month month-to-month, $129 for 3 months, or $420/year
• Optional insurance-eligible video visits; self-pay video visit $150
• Medication is separate from the membership; Evernow says medication may be covered by insurance when fulfilled through a local pharmacy, while some medications are cash-pay through partner pharmacies
• FDA-approved estradiol (oral and patch) and micronized progesterone
• App-based platform with symptom tracking
• Available in all 50 states plus D.C.

Why we ranked it #3:Evernow’s $49/month membership is one of the lowest-friction recurring costs for online menopause care. The app and messaging access make it feel less transactional than one-off visit models.

Who should NOT pick Evernow: If you want medication bundled into the membership price; if you dislike monthly subscriptions; if you need a comprehensive in-person workup before starting.

Winona — Best for compounded / bioidentical-focused care

Verified facts (May 26, 2026):

• Estrogen body cream + progesterone from $89/month (compounded)
• Estrogen patch from $149/month (Winona states FDA-approved)
• Vaginal estrogen cream from $89/month
• Estrogen tablets from $54/month (Winona states FDA-approved)
• Progesterone capsules from $39/month (Winona states FDA-approved)
• No membership fee; pay per medication
• Does not accept insurance; HSA/FSA-eligible
• Board-certified OB-GYN prescribers
• Uses 503A-regulated compounding pharmacies for its compounded formulations
• Does not require lab work to prescribe
• Available in listed states and Puerto Rico (verify your state at intake)

Why we ranked it #4: Winona is the cleanest option in the compounded / bioidentical-focused category, and the fact that it offers both FDA-approved and compounded options under one roof is a real advantage if you want flexibility.

The caveat we will not bury:Winona’s body creams are compounded. The FDA states clearly that it does notverify compounded drugs for safety, effectiveness, or quality before they’re marketed. ACOG and The Menopause Society both recommend FDA-approved formulations be tried first.

Who should NOT pick Winona: First-time HRT patients who specifically want a provider that prescribes only FDA-approved medications; readers who want insurance to cover their medication.

Gennev — Best for a scheduled doctor-visit model

Verified facts (May 26, 2026):

• Initial visit: 30-minute virtual appointment with a board-certified, menopause-trained doctor
• Self-pay: $250 initial / $199 follow-up
• Insurance accepted with standard copay/deductible
• FDA-approved hormone therapy by default
• Does not recommend compounded bioidentical hormones as a default
• Video appointments available in every state

Why it’s on the list:Gennev’s doctor-visit model is structured, scheduled, and feels more like a traditional in-person appointment. Some women want that; others find it overkill for a routine HRT refill.

Who should NOT pick Gennev: If you want the lowest possible entry cost; if you want a flat-rate subscription; if you need same-day prescribing.

Pandia Health — Best for continuity and refill ease

Verified facts (May 26, 2026):

• Menopause membership: $34.99/month on the 1-year plan, $59/month on the 3-month plan, $69/month on the monthly plan
• Medication is not included in the membership fee
• Accepts most major insurance plans for medication; pharmacy accepts some Medicaid plans for medication
• HSA/FSA accepted
• 30-day cancellation notice required; early cancellation fee may apply
• Offers FDA-approved bioidentical and non-hormonal medication options in multiple delivery forms (pills, patches, creams, rings, suppositories)
• State availability [verify in intake]

Why it’s on the list:Pandia’s delivery-method variety is unusually broad. The $34.99/month annual plan is the lowest monthly-equivalent membership in this comparison.

Who should NOT pick Pandia:If you want medication bundled into one price; if you might cancel within the first few months (early-cancellation fee); if you’re outside the states they currently serve.

Wisp — Best low-cost option for vaginal estrogen / local symptoms

Verified facts (May 26, 2026):

• Menopause consultation: $99
• Estradiol vaginal cream from $20
• Medications can be sent same-day to a local pharmacy if prescribed
• HSA/FSA-eligible
• FDA-approved estradiol vaginal cream
• Available in most U.S. states [verify in intake]

Why it’s on the list: For local-only treatment of vaginal estrogen, $20/month is genuinely cheap. Wisp is well-known for sexual health and has a fast, defined-symptom intake.

Who should NOT pick Wisp: If you have systemic menopause symptoms (hot flashes, night sweats, mood changes, sleep disruption) — you need a full systemic HRT regimen, not just vaginal cream. Wisp is the right tool for one specific job.

Hers — Honorable mention (familiar brand, low-friction intake)

Verified facts (May 26, 2026):

• Oral plan: $79/month on a 12-month plan
• Patch plan: $134/month on a 12-month plan
• FDA-approved estradiol (oral, patch, vaginal cream) and progesterone (oral)
• Does not accept insurance
• HSA/FSA eligible
• Not available in all 50 states (per Hers’ own disclosure)
• Hers states that HRT is not FDA-approved for perimenopause treatment but may be prescribed off-label at provider discretion
• Provider credentials: licensed providers trained in perimenopause and menopause care

Why it’s an honorable mention, not a top pick: Hers is brand-new in menopause (October 2025 launch). The clinical model is solid, the prices are visible, and the brand is mature — but the state-availability gap matters.

Who should pick Hers: Women who already use Hers for hair, weight loss, or mental health and want a unified platform; women who want a 12-month price lock; women who want a recognized consumer-health brand.

How we ranked these providers

The full methodology lives at our methodology page. The short version:

1. Clinical safety and appropriateness. Does the provider screen for contraindications, address progesterone for women with a uterus, and refuse to prescribe when telehealth isn’t the right setting?
2. Clinician access and qualifications. Real licensed clinicians, named on the site, with credentials we can verify.
3. Hormone and formulary transparency. Does the provider tell you what medications are available before intake? FDA-approved vs. compounded clearly disclosed?
4. Pricing and insurance transparency. Visible pricing for visits and medications. Clear insurance policies. No surprise EOBs.
5. Continuity and follow-up. Can you reach a clinician after the first visit? What does refill look like?
6. State availability and operational fit. Where do they serve patients? What states have they recently added or dropped?
7. Policies, trust, and patient control. Cancellation, refunds, data, communication — all visible.

We do not weight a provider’s affiliate program. Where we have an affiliate relationship, we’ll label it. Until then, every provider link goes to the provider’s home page so you can verify our claims yourself.

For a deeper head-to-head between the four most-compared providers, see Midi vs Alloy vs Winona vs Evernow. For full cost breakdowns by medication and delivery method, see HRT cost in 2026.

Mistakes to avoid when choosing your online HRT provider

Six mistakes we see all the time

1. Comparing membership prices without medication cost. A $49/month membership plus $80/month medication is more expensive than a $250 visit plus $30/month medication if you only need one visit a year. Run the 90-day math.
2. Assuming “bioidentical” means FDA-approved. It doesn’t. Some FDA-approved hormones are bioidentical. Some bioidentical hormones are compounded. They are different things.
3. Assuming insurance covers the visit AND the medication. Often it covers one and not the other. Check both before signing up.
4. Skipping the cancellation terms. Some providers require 30-day notice. Some charge early-cancellation fees. Read before you click.
5. Choosing speed when you need complexity handled. If your medical history is complicated, the cheapest, fastest provider is not the right one. Pay for the doctor visit.
6. Buying based on one Instagram ad. Every provider in this category runs ads. The good ones look like the bad ones in a 30-second video. Compare on data.

What happens after you pick a provider

The general flow:

1. Intake. You answer questions about your symptoms, medical history, current medications, and goals.
2. Clinician review. A licensed clinician reads your intake. If your history is straightforward, this often happens within 24–72 hours.
3. Prescription. If you’re eligible, you get a prescription. If you have a uterus and you’re getting systemic estrogen, you should also get progesterone.
4. Pharmacy fulfillment. Some providers ship to you directly. Others send the prescription to a local pharmacy you choose. Insurance typically applies at this step if the medication is FDA-approved and your plan covers it.
5. Follow-up. A check-in at 6–12 weeks to see how you’re doing. Many providers offer messaging access in between.
6. Adjustment. Dose changes, formulation changes, or adding adjacent treatments are normal in the first 3–6 months.

What to prepare for your first visit

• A list of your current and most bothersome symptoms
• Your menstrual history (last period, regularity)
• Whether you have a uterus
• Cancer history (yours and your immediate family’s)
• Blood clot, stroke, or heart history
• Current medications and supplements
• Insurance card if applicable
• Preferred pharmacy

Frequently asked questions

Still not sure which HRT program is right for you?

Take our free 60-second matching quiz. You’ll answer a few questions about your insurance, your symptoms, your state, and your preferences — and we’ll match you to the best-fit provider with a backup option, plus the specific questions to ask in your first consultation.

It’s free, takes about 60 seconds, and we don’t share your information with providers without your permission.

Why we built this page

The HRT Index is an independent comparison resource for HRT telehealth providers. We started this because nobody was publishing real prices, real state-availability data, and real cost math in one place. We do.

We re-verify pricing monthly for the top providers and quarterly for the full roster. The “Last verified” date at the top of this page updates with every refresh. If you spot something out of date, email us — we want to fix it.

We may earn a commission if you sign up with a provider through a labeled affiliate link. This does not influence our rankings. We’ve published our methodology so you can see exactly how we evaluate each provider.

This page was researched and written by The HRT Index editorial team. It has not been reviewed by a medical doctor. We’re a research and comparison resource — for medical advice, see a licensed clinician.

Last verified: May 26, 2026. Next refresh: June 26, 2026.

Sources

Provider pricing and policies (verified May 26, 2026):

• Midi Health pricing and insurance: joinmidi.com
• Evernow pricing and FAQ: evernow.com
• Alloy product menu and pricing: myalloy.com
• Winona shop and product menu: bywinona.com
• Gennev menopause care and pricing: gennev.com
• Pandia Health menopause membership: pandiahealth.com
• Wisp menopause shop: hellowisp.com
• Hers menopause care: forhers.com

Medical and regulatory references:

• U.S. Food and Drug Administration. “FDA Approves Labeling Changes to Menopausal Hormone Therapy Products.” February 12, 2026.
• U.S. Food and Drug Administration. “FDA Requests Labeling Changes Related to Safety Information to Clarify the Benefit/Risk Considerations for Menopausal Hormone Therapies.”
• U.S. Department of Health and Human Services. “HHS Advances Women’s Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy.” November 10, 2025.
• U.S. Food and Drug Administration. “Compounding and the FDA: Questions and Answers.”
• ACOG Clinical Consensus No. 6. “Compounded Bioidentical Menopausal Hormone Therapy.” Obstetrics & Gynecology, November 2023.
• Reuters. “Hims & Hers says it has steady estrogen patch supply amid US shortages.” April 2026.

Patient quotes attributed to publicly displayed testimonials on Midi Health (joinmidi.com) and Evernow (evernow.com). Individual results vary; testimonials are not medical efficacy claims.